These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3444059)

  • 1. [Detection of anterior pituitary cell surface antibodies with Hashimoto's disease and Graves' disease].
    Sugiura M; Hashimoto A; Yokoi Y; Maruyama S; Ishido T; Mori M; Yamaguchi T; Kobayashi I
    Rinsho Byori; 1987 Nov; 35(11):1250-6. PubMed ID: 3444059
    [No Abstract]   [Full Text] [Related]  

  • 2. Anterior pituitary cell antibodies detected in Hashimoto's thyroiditis and Graves' disease.
    Kobayashi I; Inukai T; Takahashi M; Ishii A; Ohshima K; Mori M; Shimomura Y; Kobayashi S; Hashimoto A; Sugiura M
    Endocrinol Jpn; 1988 Oct; 35(5):705-8. PubMed ID: 3220050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases.
    Selenkow HA; Wyman P; Allweiss P
    Compr Ther; 1984 Apr; 10(4):48-56. PubMed ID: 6373115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of the antigliadin antibodies in autoimmune thyroid diseases.
    Akçay MN; Akçay G
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclxxix-cclxxx. PubMed ID: 15244201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease.
    Hopf U; Fiek T; Grün R; Zuschneid W
    J Clin Lab Immunol; 1982 Oct; 9(1):49-53. PubMed ID: 6757440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary-cell autoantibody diversity in sera from patients with untreated Graves' disease.
    Hansen BL; Hegedüs L; Hansen GN; Hagen C; Hansen JM; Høier-Madsen M
    Autoimmunity; 1989; 5(1-2):49-57. PubMed ID: 2519017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistological phenotyping of thyroid infiltrating lymphocytes in Graves' disease and Hashimoto's thyroiditis.
    Misaki T; Konishi J; Nakashima T; Iida Y; Kasagi K; Endo K; Uchiyama T; Kuma K; Torizuka K
    Clin Exp Immunol; 1985 Apr; 60(1):104-10. PubMed ID: 3891164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
    Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
    J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of immunoregulatory T cells in human thyroid autoimmunity: influence of thyroid status.
    Bonnyns M; Bentin J; Devetter G; Duchateau J
    Clin Exp Immunol; 1983 Jun; 52(3):629-34. PubMed ID: 6223729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral K lymphocytes in autoimmune thyroid disease: decrease in Graves' disease and increase in Hashimoto's disease.
    Amino N; Mori H; Iwatani Y; Asari S; Izumiguchi Y; Miyai K
    J Clin Endocrinol Metab; 1982 Mar; 54(3):587-91. PubMed ID: 7035486
    [No Abstract]   [Full Text] [Related]  

  • 11. Graves' ophthalmopathy, ocular myasthenia gravis and Hashimoto's thyroiditis.
    Czernobilsky H; Ziegler R
    Isr J Med Sci; 1985 Apr; 21(4):377-80. PubMed ID: 3873447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA antigens in Japanese patients with Graves' disease and Hashimoto's disease [proceedings].
    Konishi J; Grumet FC; Payne RO; Mori T; Kriss JP
    Diabete Metab; 1976 Sep; 2(3):163-4. PubMed ID: 1036991
    [No Abstract]   [Full Text] [Related]  

  • 13. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenetic connection between Graves' disease and chronic lymphocytic thyroiditis. (The role and incidence of thyroid stimulating antibodies).
    Leövey A; Bakó G; Sztojka I; Bordán L; Szabó T; Kálmán K; Balázs C
    Acta Med Acad Sci Hung; 1982; 39(1-2):1-6. PubMed ID: 6129766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Organ-specific autoimmune diseases and cytokines].
    Hidaka Y; Amino N
    Rinsho Byori; 1999 Apr; 47(4):335-9. PubMed ID: 10340007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoimmune thyroid pathology. Study and follow-up of pediatric case reports].
    Pocecco M; Barbi E; De Campo C
    Pediatr Med Chir; 1986; 8(5):691-4. PubMed ID: 3496586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic aspects of Graves' and Hashimoto's diseases.
    Kidd A; Okita N; Row VV; Volpé R
    Metabolism; 1980 Jan; 29(1):80-99. PubMed ID: 6986013
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of IL-10 and IL-12 in CD40 and interleukin 4-activated mononuclear cells from patients with Graves' disease.
    Itoh M; Uchimura K; Makino M; Kobayashi T; Hayashi R; Nagata M; Kakizawa H; Fujiwara K; Nagasaka A
    Cytokine; 2000 Jun; 12(6):688-93. PubMed ID: 10843746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid autoantigen-induced lymphocyte proliferation in Graves' disease and Hashimoto's thyroiditis.
    Weetman AP; Gunn C; Hall R; McGregor AM
    J Clin Lab Immunol; 1985 May; 17(1):1-6. PubMed ID: 3876444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto's disease, Graves' disease and a follow-up study on postpartum thyroid disease.
    Gilmour J; Brownlee Y; Foster P; Geekie C; Kelly P; Robertson S; Wade E; Braun HB; Staub U; Michel G; Lazarus JH; Parkes AB
    Clin Lab; 2000; 46(1-2):57-61. PubMed ID: 10745983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.